| 000 | 01319 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513213825.0 | ||
| 264 | 0 | _c20000725 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0266-9536 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFabbro, D | |
| 245 | 0 | 0 |
_aPKC412--a protein kinase inhibitor with a broad therapeutic potential. _h[electronic resource] |
| 260 |
_bAnti-cancer drug design _cFeb 2000 |
||
| 300 |
_a17-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStaurosporine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aRuetz, S | |
| 700 | 1 | _aBodis, S | |
| 700 | 1 | _aPruschy, M | |
| 700 | 1 | _aCsermak, K | |
| 700 | 1 | _aMan, A | |
| 700 | 1 | _aCampochiaro, P | |
| 700 | 1 | _aWood, J | |
| 700 | 1 | _aO'Reilly, T | |
| 700 | 1 | _aMeyer, T | |
| 773 | 0 |
_tAnti-cancer drug design _gvol. 15 _gno. 1 _gp. 17-28 |
|
| 999 |
_c10838527 _d10838527 |
||